Pharmaceutical

Aspect wins $72.75m from Canadian government for bioprinted pipeline

Novo Nordisk-partnered Aspect develops bioprinted tissue therapeutics designed to replace or support specific biological functions.

Jul 12, 2024 - 04:00
Aspect wins $72.75m from Canadian government for bioprinted pipeline
Novo Nordisk-partnered Aspect develops bioprinted tissue therapeutics designed to replace or support specific biological functions.
Read the original article

Tags:

Previous Article

Merz wins $185m bid for bankrupt Acorda assets and increases US workforce by 50%

Next Article

After AdCom rejection, FDA rebuffs Novo Nordisk’s once-weekly insulin

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Related Posts

STAT+: Syndax’s leukemia drug succeeds in pivotal study

STAT+: Syndax’s leukemia drug succeeds in pivotal study

Oct 2, 2023

Carmot’s chance of beating the odds in the biotech market just ended

Carmot’s chance of beating the odds in the biotech mark...

Dec 5, 2023

CDC recommends rationing of RSV shot due to shortages

CDC recommends rationing of RSV shot due to shortages

Oct 24, 2023